Testing the ability of JNJ-18038683, a selective serotonin (5-HT)7 antagonist, to improve cognition and reduce residual depressive symptoms in stable bipolar patients

Project: Research project

Project Details

StatusActive
Effective start/end date5/13/1512/31/20

Funding

  • Janssen Research & Development, LLC (Prot #STU00200919)